Nitrofurantoin: properties and potential in treatment of urinary tract infection: a narrative review. 2023

Marzie Mahdizade Ari, and Shirin Dashtbin, and Fatemeh Ghasemi, and Soheila Shahroodian, and Parisa Kiani, and Elnaz Bafandeh, and Talieh Darbandi, and Roya Ghanavati, and Atieh Darbandi
Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Nitrofurantoin (NF), a wide-spectrum antibiotic accessible since 1953, is utilized widely to treat urinary tract infections as it usually stays active against drug-resistant uropathogen. The use of Nitrofurantoin has increased exponentially since new guidelines have repositioned it as first-line therapy for uncomplicated lower urinary tract infection (UTI). To, although fluoroquinolones are usually used to re-evaluate the first- and second-line therapies for treating uncomplicated UTI, their level of utilization is thought to be inappropriately excessive and will eventually have a detrimental impact; thus, we hypothesize that NF might be the best choice for this condition, because of its low frequency of utilization and its high susceptibility in common UTI pathogens. It can be concluded from this review that NF can be considered as the most effective drug in the treatment of acute urinary infection, but due to the long-term side effects of this drug, especially in elderly patients, it is essential to introduce some criteria for prescribing NF in cases of chronic UTI.

UI MeSH Term Description Entries
D009582 Nitrofurantoin A urinary anti-infective agent effective against most gram-positive and gram-negative organisms. Although sulfonamides and antibiotics are usually the agents of choice for urinary tract infections, nitrofurantoin is widely used for prophylaxis and long-term suppression. Furadantin,Furadantine,Furadoine,Furadonine,Furantoin,Macrodantin,Nitrofurantoin Sodium Salt,Nitrofurantoin, Monohydrate
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D014552 Urinary Tract Infections Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA. Infection, Urinary Tract,Infections, Urinary Tract,Tract Infection, Urinary,Tract Infections, Urinary,Urinary Tract Infection
D024841 Fluoroquinolones A group of QUINOLONES with at least one fluorine atom and a piperazinyl group. Fluoroquinolone

Related Publications

Marzie Mahdizade Ari, and Shirin Dashtbin, and Fatemeh Ghasemi, and Soheila Shahroodian, and Parisa Kiani, and Elnaz Bafandeh, and Talieh Darbandi, and Roya Ghanavati, and Atieh Darbandi
January 2024, Cureus,
Marzie Mahdizade Ari, and Shirin Dashtbin, and Fatemeh Ghasemi, and Soheila Shahroodian, and Parisa Kiani, and Elnaz Bafandeh, and Talieh Darbandi, and Roya Ghanavati, and Atieh Darbandi
October 1957, A.M.A. archives of internal medicine,
Marzie Mahdizade Ari, and Shirin Dashtbin, and Fatemeh Ghasemi, and Soheila Shahroodian, and Parisa Kiani, and Elnaz Bafandeh, and Talieh Darbandi, and Roya Ghanavati, and Atieh Darbandi
August 2019, Journal of the neurological sciences,
Marzie Mahdizade Ari, and Shirin Dashtbin, and Fatemeh Ghasemi, and Soheila Shahroodian, and Parisa Kiani, and Elnaz Bafandeh, and Talieh Darbandi, and Roya Ghanavati, and Atieh Darbandi
February 1974, The New England journal of medicine,
Marzie Mahdizade Ari, and Shirin Dashtbin, and Fatemeh Ghasemi, and Soheila Shahroodian, and Parisa Kiani, and Elnaz Bafandeh, and Talieh Darbandi, and Roya Ghanavati, and Atieh Darbandi
December 1971, Lancet (London, England),
Marzie Mahdizade Ari, and Shirin Dashtbin, and Fatemeh Ghasemi, and Soheila Shahroodian, and Parisa Kiani, and Elnaz Bafandeh, and Talieh Darbandi, and Roya Ghanavati, and Atieh Darbandi
January 1972, Lancet (London, England),
Marzie Mahdizade Ari, and Shirin Dashtbin, and Fatemeh Ghasemi, and Soheila Shahroodian, and Parisa Kiani, and Elnaz Bafandeh, and Talieh Darbandi, and Roya Ghanavati, and Atieh Darbandi
December 1971, Lancet (London, England),
Marzie Mahdizade Ari, and Shirin Dashtbin, and Fatemeh Ghasemi, and Soheila Shahroodian, and Parisa Kiani, and Elnaz Bafandeh, and Talieh Darbandi, and Roya Ghanavati, and Atieh Darbandi
February 2019, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia,
Marzie Mahdizade Ari, and Shirin Dashtbin, and Fatemeh Ghasemi, and Soheila Shahroodian, and Parisa Kiani, and Elnaz Bafandeh, and Talieh Darbandi, and Roya Ghanavati, and Atieh Darbandi
April 1956, Journal of the American Medical Association,
Marzie Mahdizade Ari, and Shirin Dashtbin, and Fatemeh Ghasemi, and Soheila Shahroodian, and Parisa Kiani, and Elnaz Bafandeh, and Talieh Darbandi, and Roya Ghanavati, and Atieh Darbandi
April 1957, Vie medicale (Paris, France : 1920),
Copied contents to your clipboard!